{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:24:04Z","timestamp":1761675844785},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T00:00:00Z","timestamp":1302307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10585-011-9387-7","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T18:07:51Z","timestamp":1302286071000},"page":"505-514","source":"Crossref","is-referenced-by-count":16,"title":["Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL\/RANK signalling really important?"],"prefix":"10.1007","volume":"28","author":[{"given":"J.","family":"Costa-Rodrigues","sequence":"first","affiliation":[]},{"given":"C. A.","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"M. H.","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,4,9]]},"reference":[{"key":"9387_CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann NY Acad Sci 1092:385\u2013396","journal-title":"Ann NY Acad Sci"},{"key":"9387_CR2","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318\u20133325","journal-title":"J Clin Invest"},{"key":"9387_CR3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13:791\u2013801","journal-title":"Nat Med"},{"key":"9387_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10585-007-9112-8","volume":"24","author":"P Clezardin","year":"2007","unstructured":"Clezardin P, Teti A (2007) Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastas 24:599\u2013608","journal-title":"Clin Exp Metastas"},{"key":"9387_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jcp.2007.048868","volume":"61","author":"HK Datta","year":"2008","unstructured":"Datta HK, Ng WF, Walker JA et al (2008) The cell biology of bone metabolism. J Clin Pathol 61:577\u2013587","journal-title":"J Clin Pathol"},{"key":"9387_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139\u2013146","journal-title":"Arch Biochem Biophys"},{"key":"9387_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo K, Irie N (2008) Osteoclast\u2013osteoblast communication. Arch Biochem Biophys 473:201\u2013209","journal-title":"Arch Biochem Biophys"},{"key":"9387_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"9387_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/CS19990355","volume":"99","author":"GC Nicholson","year":"2000","unstructured":"Nicholson GC, Malakellis M, Collier FM et al (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 99:133\u2013140","journal-title":"Clin Sci (Lond)"},{"key":"9387_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1359\/jbmr.0301215","volume":"19","author":"YS Hu","year":"2004","unstructured":"Hu YS, Zhou H, Myers D et al (2004) Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. J Bone Miner Res 19:89\u201399","journal-title":"J Bone Miner Res"},{"key":"9387_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim N, Kadono Y, Takami M et al (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589\u2013595","journal-title":"J Exp Med"},{"key":"9387_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00264-002-0407-8","volume":"27","author":"M San-Julian","year":"2003","unstructured":"San-Julian M, Diaz-de-Rada P, Noain E et al (2003) Bone metastases from osteosarcoma. Int Orthop 27:117\u2013120","journal-title":"Int Orthop"},{"key":"9387_CR13","first-page":"1231","volume":"33","author":"S Avnet","year":"2008","unstructured":"Avnet S, Longhi A, Salerno M et al (2008) Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol 33:1231\u20131238","journal-title":"Int J Oncol"},{"key":"9387_CR14","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1158\/1535-7163.MCT-08-0530","volume":"7","author":"T Akiyama","year":"2008","unstructured":"Akiyama T, Dass CR, Choong PF (2008) Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Mol Cancer Ther 7:3461\u20133469","journal-title":"Mol Cancer Ther"},{"key":"9387_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10585-010-9319-y","volume":"27","author":"T Akiyama","year":"2010","unstructured":"Akiyama T, Choong PF, Dass CR (2010) RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells. Clin Exp Metastas 27:207\u2013215","journal-title":"Clin Exp Metastas"},{"key":"9387_CR16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1211\/jpp.62.04.0009","volume":"62","author":"T Akiyama","year":"2010","unstructured":"Akiyama T, Dass CR, Shinoda Y et al (2010) Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts. J Pharm Pharmacol 62:470\u2013476","journal-title":"J Pharm Pharmacol"},{"key":"9387_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1567-5769(01)00134-5","volume":"2","author":"N Miyamoto","year":"2002","unstructured":"Miyamoto N, Higuchi Y, Mori K et al (2002) Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells. Int Immunopharmacol 2:25\u201338","journal-title":"Int Immunopharmacol"},{"key":"9387_CR18","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1359\/jbmr.2000.15.9.1766","volume":"15","author":"K Itoh","year":"2000","unstructured":"Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T et al (2000) Importance of membrane- or matrix-associated forms of M-CSF and RANKL\/ODF in osteoclastogenesis supported by SaOS-4\/3 cells expressing recombinant PTH\/PTHrP receptors. J Bone Miner Res 15:1766\u20131775","journal-title":"J Bone Miner Res"},{"key":"9387_CR19","doi-asserted-by":"crossref","first-page":"C811","DOI":"10.1152\/ajpcell.00504.2004","volume":"289","author":"T Kawase","year":"2005","unstructured":"Kawase T, Okuda K, Burns DM (2005) Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm)(2,7)] calcitonin gene-related peptide and CGRP(8\u201337). Am J Physiol Cell Physiol 289:C811\u2013C818","journal-title":"Am J Physiol Cell Physiol"},{"key":"9387_CR20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/1097-4644(20000915)78:4<627::AID-JCB12>3.0.CO;2-3","volume":"78","author":"HC Blair","year":"2000","unstructured":"Blair HC, Sidonio RF, Friedberg RC et al (2000) Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78:627\u2013637","journal-title":"J Cell Biochem"},{"key":"9387_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbm.a.30025","volume":"70","author":"S Lossdorfer","year":"2004","unstructured":"Lossdorfer S, Schwartz Z, Wang L et al (2004) Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J Biomed Mater Res 70:361\u2013369","journal-title":"J Biomed Mater Res"},{"key":"9387_CR22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0142-9612(01)00371-4","volume":"23","author":"D Granchi","year":"2002","unstructured":"Granchi D, Cenni E, Savarino L et al (2002) Bone cement extracts modulate the osteoprotegerin\/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. Biomaterials 23:2359\u20132365","journal-title":"Biomaterials"},{"key":"9387_CR23","first-page":"509","volume":"24","author":"RS Taichman","year":"1996","unstructured":"Taichman RS, Emerson SG (1996) Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: identification and partial characterization of cell-associated isoforms. Exp Hematol 24:509\u2013517","journal-title":"Exp Hematol"},{"key":"9387_CR24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-079X.2007.00464.x","volume":"43","author":"CD Toma","year":"2007","unstructured":"Toma CD, Svoboda M, Arrich F et al (2007) Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. J Pineal Res 43:206\u2013213","journal-title":"J Pineal Res"},{"key":"9387_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jcb.22398","volume":"109","author":"J Costa-Rodrigues","year":"2010","unstructured":"Costa-Rodrigues J, Teixeira CA, Sampaio P et al (2010) Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media. J Cell Biochem 109:205\u2013216","journal-title":"J Cell Biochem"},{"key":"9387_CR26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"9387_CR27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcb.21167","volume":"101","author":"H Hotokezaka","year":"2007","unstructured":"Hotokezaka H, Sakai E, Ohara N et al (2007) Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-\u03b1, lipopolysaccharide, or peptidoglycan. J Cell Biochem 101:122\u2013134","journal-title":"J Cell Biochem"},{"key":"9387_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.regpep.2010.03.003","volume":"162","author":"M Yamashita","year":"2010","unstructured":"Yamashita M, Otsuka F, Mukai T et al (2010) Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept 162:99\u2013108","journal-title":"Regul Pept"},{"key":"9387_CR29","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","volume":"277","author":"H Hotokezaka","year":"2002","unstructured":"Hotokezaka H, Sakai E, Kanaoka K et al (2002) U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277:47366\u201347372","journal-title":"J Biol Chem"},{"key":"9387_CR30","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1038\/sj.cdd.4401403","volume":"11","author":"CR Yang","year":"2004","unstructured":"Yang CR, Wang JH, Hsieh SL et al (2004) Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte\/macrophage lineage precursor cells. Cell Death Differ 11:S97\u2013S107","journal-title":"Cell Death Differ"},{"key":"9387_CR31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2008.06.005","volume":"27","author":"Q Yang","year":"2008","unstructured":"Yang Q, McHugh KP, Patntirapong S et al (2008) VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 27:589\u2013599","journal-title":"Matrix Biol"},{"key":"9387_CR32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/mol.107.034173","volume":"72","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Lee Y, Chang EJ et al (2007) Suppression of osteoclastogenesis by N,N-dimethyl-d-erythro-sphingosine: a sphingosine kinase inhibition-independent action. Mol Pharmacol 72:418\u2013428","journal-title":"Mol Pharmacol"},{"key":"9387_CR33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/bbrc.1995.1184","volume":"207","author":"TJ Hall","year":"1995","unstructured":"Hall TJ, Schaeublin M, Jeker H et al (1995) The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 207:280\u2013287","journal-title":"Biochem Biophys Res Commun"},{"key":"9387_CR34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.06.030","volume":"572","author":"M Kellinsalmi","year":"2007","unstructured":"Kellinsalmi M, Parikka V, Risteli J et al (2007) Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro. Eur J Pharmacol 572:102\u2013110","journal-title":"Eur J Pharmacol"},{"key":"9387_CR35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10165-008-0149-6","volume":"19","author":"M Kawashima","year":"2009","unstructured":"Kawashima M, Fujikawa Y, Itonaga I et al (2009) The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro. Mod Rheumatol 19:192\u2013198","journal-title":"Mod Rheumatol"},{"key":"9387_CR36","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC et al (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445\u20139449","journal-title":"Proc Natl Acad Sci USA"},{"key":"9387_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/cbir.1996.0060","volume":"20","author":"Y Torii","year":"1996","unstructured":"Torii Y, Hitomi K, Yamagishi Y et al (1996) Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biol Int 20:459\u2013464","journal-title":"Cell Biol Int"},{"key":"9387_CR38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08977190412331279890","volume":"22","author":"D Chen","year":"2004","unstructured":"Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233\u2013241","journal-title":"Growth Factors"},{"key":"9387_CR39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","volume":"14","author":"FJ Pixley","year":"2004","unstructured":"Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14:628\u2013638","journal-title":"Trends Cell Biol"},{"key":"9387_CR40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2319","volume":"215","author":"HJ Knowles","year":"2008","unstructured":"Knowles HJ, Athanasou NA (2008) Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 215:56\u201366","journal-title":"J Pathol"},{"key":"9387_CR41","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"9387_CR42","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2741\/2252","volume":"12","author":"Q Zhao","year":"2007","unstructured":"Zhao Q, Shao J, Chen W et al (2007) Osteoclast differentiation and gene regulation. Front Biosci 12:2519\u20132529","journal-title":"Front Biosci"},{"key":"9387_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/1541-7786.MCR-08-0219","volume":"7","author":"TJ Vries de","year":"2009","unstructured":"de Vries TJ, Mullender MG, van Duin MA et al (2009) The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol Cancer Res 7:476\u2013488","journal-title":"Mol Cancer Res"},{"key":"9387_CR44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.2002.17.5.763","volume":"17","author":"R Battaglino","year":"2002","unstructured":"Battaglino R, Kim D, Fu J et al (2002) c-myc is required for osteoclast differentiation. J Bone Miner Res 17:763\u2013773","journal-title":"J Bone Miner Res"},{"key":"9387_CR45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00774-007-0753-0","volume":"25","author":"DB Logar","year":"2007","unstructured":"Logar DB, Komadina R, Pre\u017eelj J et al (2007) Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab 25:219\u2013225","journal-title":"J Bone Miner Metab"},{"key":"9387_CR46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/jcb.21719","volume":"104","author":"EW Bradley","year":"2008","unstructured":"Bradley EW, Ruan MM, Vrable A et al (2008) Pathway crosstalk between Ras\/Raf and PI3K in promotion of M-CSF-induced MEK\/ERK-mediated osteoclast survival. J Cell Biochem 104:1439\u20131451","journal-title":"J Cell Biochem"},{"key":"9387_CR47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0301-472X(99)00061-2","volume":"27","author":"GD Roodman","year":"1999","unstructured":"Roodman GD (1999) Cell biology of the osteoclast. Exp Hematol 27:1229\u20131241","journal-title":"Exp Hematol"},{"key":"9387_CR48","first-page":"521","volume":"21","author":"K Strait","year":"2008","unstructured":"Strait K, Li Y, Dillehay DL et al (2008) Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency. Int J Mol Med 21:521\u2013525","journal-title":"Int J Mol Med"},{"key":"9387_CR49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7888\/juoeh.25.185","volume":"25","author":"Y Okada","year":"2003","unstructured":"Okada Y, Pilbeam C, Raisz L et al (2003) Role of cyclooxygenase-2 in bone resorption. J UOEH 25:185\u2013195","journal-title":"J UOEH"},{"key":"9387_CR50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","volume":"21","author":"KA Blackwell","year":"2010","unstructured":"Blackwell KA, Raisz LG, Pilbeam CC (2010) Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab 21:294\u2013301","journal-title":"Trends Endocrinol Metab"},{"key":"9387_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1163\/156856201750180951","volume":"12","author":"E Cenni","year":"2001","unstructured":"Cenni E, Granchi D, Ciapetti G et al (2001) Interleukin-6 expression by osteoblast-like MG63 cells challenged with four acrylic bone cements. J Biomater Sci 12:243\u2013253","journal-title":"J Biomater Sci"},{"key":"9387_CR52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","volume":"97","author":"SM Kakonen","year":"2003","unstructured":"Kakonen SM, Mundy GR (2003) Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97:834\u2013839","journal-title":"Cancer"},{"key":"9387_CR53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jcb.21214","volume":"101","author":"C Morrissey","year":"2007","unstructured":"Morrissey C, Vessella RL (2007) The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem 101:873\u2013886","journal-title":"J Cell Biochem"},{"key":"9387_CR54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0707232","volume":"151","author":"H Michael","year":"2007","unstructured":"Michael H, Harkonen PL, Kangas L et al (2007) Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro. Br J Pharmacol 151:384\u2013395","journal-title":"Br J Pharmacol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-011-9387-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9387-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:23:02Z","timestamp":1712362982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-011-9387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,9]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["9387"],"URL":"https:\/\/doi.org\/10.1007\/s10585-011-9387-7","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,9]]}}}